News

EMA Starts Rolling Review of Adapted COVID-19 Vaccines

June 21, 2022

The agency will review laboratory study and CMC data on the bivalent vaccine that targets two strains of the SARS-CoV-2 virus.

International Collaboration on Pharmaceutical Regulations

June 21, 2022

Lessons learned from the COVID-19 pandemic about the benefits of international collaboration were discussed in a May 2022 workshop.

Avid Bioservices Launches New Analytical and Process Development Suites at Viral Vector Facility

June 21, 2022

Avid Bioservices has expanded its viral vector development and manufacturing facility with the addition of analytical and process development suites.

Orbit Discovery Awarded Innovate UK Grant

June 21, 2022

Orbit Discovery has been awarded the Innovate UK Grant to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery.

FDA Authorizes COVID-19 Vaccines for Individuals Six Months and Older

June 17, 2022

FDA has issued an Emergency Use Authorization for the Moderna and Pfizer-BioNTech COVID-19 vaccines in children as young as six months old.

Batavia Biosciences Increases Capacity for Viral Vectors and Vaccine R&D in the Netherlands

June 17, 2022

Batavia Biosciences is expanding its headquarters and R&D capabilities in its Netherlands facility.

Aptamer Group Signs Deal with Flip Gene Therapeutics

June 17, 2022

Aptamer Group has signed a deal with Flip Gene Therapeutics to support the development of inducible gene therapies.

SCHOTT to Triple Vial Production Capacity in the US

June 17, 2022

SCHOTT is planning to triple its ready-to-use vial production capacity in the United States to meet increasing demand for storing injectable drugs.

Boehringer Ingelheim to Acquire Trutino Biosciences

June 17, 2022

Boehringer Ingelheim has signed an option to acquire Trutino Biosciences.

FDA User Fee Legislation Advances in Senate

June 17, 2022

Measure tackles infant formula, cosmetics, diagnostics plus drug development and access.